Timing of Finasteride Administration
Finasteride can be taken at any time of day, with or without food, as its bioavailability is not affected by food intake and DHT suppression is maintained throughout the 24-hour dosing interval 1.
Pharmacokinetic Rationale
The timing flexibility of finasteride is supported by its pharmacodynamic profile:
- Maximum DHT suppression occurs 8 hours after a single dose, but the suppression is maintained throughout the entire 24-hour period with daily dosing 1
- Food does not affect bioavailability, eliminating the need to coordinate dosing with meals 1
- The drug has a 6-hour plasma half-life (range 3-16 hours), but forms an extremely stable enzyme complex with Type II 5α-reductase that has a turnover half-life of approximately 30 days 1
- Peak plasma concentration is reached 1-2 hours post-dose, averaging 37 ng/mL 1
Practical Dosing Recommendations
For BPH (5 mg daily):
- Choose a consistent time each day to optimize adherence
- Morning or evening dosing are equally effective
- No need to avoid food or coordinate with other medications (unless specific drug interactions exist)
For Androgenetic Alopecia (1 mg daily):
- Same flexibility applies as with the 5 mg dose
- Consistency in timing helps with medication adherence but does not affect efficacy
- The biologic effect on DHT suppression is dose-dependent but timing-independent
Key Clinical Considerations
The most important factor is daily consistency rather than specific timing. The drug's mechanism—forming a stable, long-lasting enzyme complex—means that:
- Missing doses has more impact than timing variations
- Steady-state concentrations are reached after multiple doses, with accumulation occurring over 17+ days 1
- In older patients (≥70 years), plasma concentrations are 54% higher after 17 days compared to first dose, but this reflects accumulation, not timing effects 1
Common Pitfall to Avoid:
Do not counsel patients that finasteride must be taken at a specific time of day or with/without food. This creates unnecessary barriers to adherence. The evidence clearly demonstrates that timing flexibility should be emphasized to patients to improve long-term compliance, which is critical given that finasteride requires continuous use to maintain benefits 1, 2.